Clinical Trial Update: Safety Study of Multiple Peptide Vaccine to Esophageal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 safety study of a multiple peptide vaccine for esophageal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Multiple Peptide Vaccine

Snippet

Sponsor: Japanese Foundation for Cancer Research | Conditions: Esophageal Cancer | Phase 1 | Status: COMPLETED